FDA warns on infant CPAP systems following dozens of complaints

FDA regulators put their highest-risk warning on Fisher & Paykel Healthcare's recall of infant CPAP prongs after receiving complaints that they detached from their tubing.

FDA regulators put their highest-level warning on Fisher & Paykel's recall of infant CPAP components, warning that the defect may pose a choking risk to babies.

Fisher & Paykel Healthcare, Food & Drug Administration (FDA)

News Well, Food & Drug Administration (FDA), Pediatrics, Recalls, Regulatory/Compliance, Respiratory

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1nbe8Cj